Canbio Pharmaceuticals LLP
About Canbio Pharmaceuticals LLP
Data last updated:
Canbio Pharmaceuticals LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 June 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAS-5978. Its GSTIN is 24AAPFC4083N1ZZ (Gujarat).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Bhupendrabhai Valjibhai Patel and Rabindra Kumar Mohanty.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Plot No 247 248 1 Phase 1 G.I.D.C Naroda, Ahmedabad, Gujarat, India – 382330.
As per the financials filed for FY 2024, the LLP reported a revenue of ₹9.1 Cr, a growth of 121.05% compared to the previous year.
As per MCA filings, the LLP has open charges of ₹7.15 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No 247 248 1 Phase 1 G.I.D.C Naroda, Ahmedabad, Gujarat, India – 382330
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Designated Partners of Canbio Pharmaceuticals LLP
Canbio Pharmaceuticals has 8 current designated partners and 6 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhupendrabhai Valjibhai Patel | Designated Partner | 12 Jun 2020 | 6 Years 3 Months | Current |
| Rabindra Kumar Mohanty | Designated Partner | 02 Sep 2020 | 6 Years 1 Months | Current |
| Bharatkumar Vitthalbhai Patel Also directs: Odhav Enviro Projects Limited | Designated Partner | 03 Oct 2024 | 2 Years 0 Months | Current |
| Pathik Bharatkumar Sheladia | Designated Partner | 01 Sep 2022 | 4 Years 1 Months | Current |
| Harsukhbhai Jasmatbhai Vekaria Also directs: Indo Multi Tradelink LLP, Petro Sol Multi Color LLP | Designated Partner | 12 Jun 2020 | 6 Years 3 Months | Current |
| Kishorkumar Vrajlal Rakholiya | Designated Partner | 03 Oct 2024 | 2 Years 0 Months | Current |
Financials of Canbio Pharmaceuticals LLP FY 2025 filings available
Canbio Pharmaceuticals LLP reported revenue of ₹9.1 Cr (up 121.05% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Canbio Pharmaceuticals LLP
Revenue rose 121.05% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Canbio Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Income | ₹9.1 Cr | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• |
| Assets and Liabilities | ||||
| Partners' Contribution | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Canbio Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Canbio Pharmaceuticals are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Canbio Pharmaceuticals LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Canbio Pharmaceuticals LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Dec 2024 | Icici Bank Limited | ₹75 Lakh | Open |
| 24 Dec 2024 | Icici Bank Limited | ₹3.4 Cr | Open |
| 15 Feb 2021 | Bank of Baroda | ₹3 Cr | Open |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Canbio Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Canbio Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Canbio Pharmaceuticals LLP
Canbio Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAPFC4083N1ZZ | Gujarat | Active | 28 Jul 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Canbio Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Canbio Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Canbio Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Canbio Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Canbio Pharmaceuticals LLP
Frequently Asked Questions about Canbio Pharmaceuticals LLP
Canbio Pharmaceuticals is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 12 June 2020 (6+ years old) and is registered under LLPIN AAS-5978.
Canbio Pharmaceuticals reported revenue of ₹9.1 Cr for FY 2024 (up 121.05% YoY).
Canbio Pharmaceuticals has 8 current designated partners:
- Bhupendrabhai Valjibhai Patel - Designated Partner
- Rabindra Kumar Mohanty - Designated Partner
- Bharatkumar Vitthalbhai Patel - Designated Partner
- Pathik Bharatkumar Sheladia - Designated Partner
- Harsukhbhai Jasmatbhai Vekaria - Designated Partner
- Kishorkumar Vrajlal Rakholiya - Designated Partner
- Dwij Kishorbhai Rakholiya - Designated Partner
- Rahul Rajaram Kondekar - Designated Partner
The GSTIN of Canbio Pharmaceuticals is 24AAPFC4083N1ZZ, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Canbio Pharmaceuticals is AAS-5978. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Canbio Pharmaceuticals was incorporated on 12 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The registered office of Canbio Pharmaceuticals is at Plot No 247 248 1 Phase 1 G.I.D.C Naroda, Ahmedabad, Gujarat, India – 382330.
The total obligation of contribution is ₹1 Lakh.
Canbio Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.